title: Lebetin peptides: potent platelet aggregation inhibitors.
abstract: Lebetins from Macrovipera lebetina snake venom constitute a new class of inhibitors of platelet aggregation. There are two groups of peptides: lebetin 1 (L1; 11- to 13-mer) and lebetin 2 (L2; 37- to 38-mer). The short lebetins are identical to the N-terminal segments of the longer ones. They inhibit platelet aggregation induced by various agonists (e.g. thrombin, PAF-acether or collagen). The shortest lebetin (11-mer) shows potent inhibition of rabbit (IC(50) = 7 nM) and human (IC(50) = 5 nM) platelets. They prevent collagen-induced thrombocytopenia in rats. N- and C-terminal-truncated synthetic L1gamma (sL1gamma; 11-mer) is less active in inhibiting platelet aggregation than the native peptide. Results from Ala scan studies of the sL1gamma peptide indicated that replacement of the residues (P3, G7, P8, P9 or N10) resulted in a remarkable drop in the activity, whereas replacement of residues K2, P4 or K6 by Ala resulted in enhancement of the antiplatelet activity by at least 10-fold. To examine the activity of multimeric L1gamma, several multimeric peptides were synthesized using the multiple-antigen peptide system assembled on a branched lysine core and their antiplatelet activity was evaluated in vitro. The largest multimeric peptides showed a 1,000-fold increase in antiplatelet activity.
authors.affiliation: Laboratoire des Venins et Toxines, Institut Pasteur de Tunis, 13 Place Pasteur, BP 74, 1002 Tunis-Belvédère, Tunisia. naziha.marrakchi@pasteur.rns.tn
authors.forename: N
authors.initials: N
authors.lastname: Marrakchi
authors.forename: K
authors.initials: K
authors.lastname: Mabrouk
authors.forename: I
authors.initials: I
authors.lastname: Regaya
authors.forename: S
authors.initials: S
authors.lastname: Sarray
authors.forename: M
authors.initials: M
authors.lastname: Fathallah
authors.forename: H
authors.initials: H
authors.lastname: Rochat
authors.forename: M
authors.initials: M
authors.lastname: El Ayeb
mesh_terms: D000818:Animals; D001792:Blood Platelets / Q000187:drug effects; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000737:chemistry / Q000302:isolation & purification / Q000494:pharmacology*; D013329:Structure-Activity Relationship; D013921:Thrombocytopenia / Q000188:drug therapy; D014757:Viper Venoms / Q000737:chemistry / Q000302:isolation & purification / Q000494:pharmacology*
chemical_list: D010975:Platelet Aggregation Inhibitors; D014757:Viper Venoms; C101100:lebetin 1; C101101:lebetin 2